The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D05 | Antipsoriatics | |
| 3 | D05A | Antipsoriatics for topical use | |
| 4 | D05AC | Antracen derivatives |
| Code | Title | |
|---|---|---|
| D05AC01 | Other antipsoriatics for topical use | |
| D05AC51 | Dithranol, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Dithranol |
Dithranol has been used in the treatment of sub-acute and chronic psoriasis for over 70 years and, during that time it has become established as a safe and effective form of therapy. Its precise mode of action is still to be confirmed, although it has been shown to inhibit DNA replication, cellular respiration and key cellular enzymes eg glucose-6-phosphate dehydrogenase. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DITHROCREAM Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
